JPRN-UMIN000010461
Completed
未知
Efficacy evaluation of intravitreal aflibercept for polypoidal choroidal vasculopathy - Efficacy evaluation of intravitreal aflibercept for polypoidal choroidal vasculopathy
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Yokohama City University Medical Center
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Lesion size \>\=12 disc area (1 disc rea is 30\.5mm2\). 'Lesion' includes hemorrhage, scar, and CNV. 2\) Area of subretinal hemorrage in study eye\>\=50% of total lesion area 3\) Area of scar or fibrosis in study eye\>\=50% of total lesion area 4\) RPE tear in study eye 5\) Stage 3 or 4 macular hole in study eye 6\) Administration of triamcinolone to study eye within 6 months prior to this study 7\) Administration of dexamethasone to study eye within 30 days prior to this study 8\) Intraocular surgery to study eye within 6 months prior to this study 9\) Any history of vitrectomy in study eye 10\) Any inflammation or infection in intra\-or extra\-ocular tissue in either eye 11\) History of uveitis in either eye 12\) Allergy to fluorescein, indocyanine or iodine 13\) pregnant women and nursing mothers 14\) Patients who were judged by docters to be inappropriate for this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
The efficacy of intravitreal aflibercept given in a ‘treat and extend’ regime in the treatment of cystoid macular oedema secondary to central retinal vein occlusion.central retinal vein occlusion (CRVO).cystoid macular oedemaEye - Diseases / disorders of the eyeACTRN12615000417583Centre for Eye Research Australia20
Completed
Phase 4
The study of Intravitreal aflibercept with treat and extend regimen for macular edema with branch retinal vein occlusion (BRVO)Branch retinal vein occlusionJPRN-UMIN000023200Department of Ophthalmology, Akita University50
Active, not recruiting
Not Applicable
Evaluation of efficacy and safety of Intravitreal bevacizumab versus intravitreal bevacizumab combined with juxtascleral anecortave acetate for the treatment exudative age-related macular degeneration - IVB JSAEUCTR2006-003170-99-ITIVERSITA DEGLI STUDI DI UDINE
Active, not recruiting
Not Applicable
Evaluation of safety and efficacy of intravitreal bevacizumab for macular edema, retinal or choroidal neovascularization or neovascular glaucoma - NDMacular oedemaMedDRA version: 6.1Level: HLGTClassification code 10047060EUCTR2006-002351-33-ITAZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA
Active, not recruiting
Not Applicable
Optical Coherence Tomography Angiography Biomarkers in a Bi-monthly Maintenance Dosing Aflibercept in Patients with Neovascular Age-Related Macular DegeneratioDiseases of the eye and adnexaKCT0007375Kyung Hee University Hospital40